SCHEMBL4364324

SCHEMBL4364324

Cc1ccc(C2=NCCN2C(c2nc(C)c(C)c(=O)n2Cc2ccccc2)C(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ KIF11 P52732 4/20 0.38
▸ KIF23 Q02241 1/20 0.38
▸ CYP2C19 P33261 2/20 0.36
▸ MAP1LC3B Q9GZQ8 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ RGS4 P49798 1/20 0.34
▸ PDE9A O76083 1/20 0.34
▸ PDE1C Q14123 1/20 0.34
▸ LMNA P02545 3/20 0.34
▸ HPGD P15428 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ TLR7 Q9NYK1 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4364853 1.00 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AKIF11KIF23
SCHEMBL4363445 0.88 PDE1C (0.39) ALDH1A1MEN1KMT2AKIF11KIF23
SCHEMBL4363455 0.85 KDM4E (0.38) ALDH1A1MEN1KMT2AKIF11KIF23
SCHEMBL4519535 0.83 KIF11 (0.53) ALDH1A1MEN1KMT2AKIF11CYP2C19
SCHEMBL4499166 0.83 ALDH1A1 (0.38) ALDH1A1MEN1KMT2AADORA3RGS4
SCHEMBL4521642 0.76 KIF11 (0.50) ALDH1A1MEN1KMT2AKIF11CYP2C19
SCHEMBL5406638 0.75 RGS4 (0.38) ALDH1A1MEN1KMT2ACYP3A4RGS4
SCHEMBL4373915 0.73 ALDH1A1 (0.41) ALDH1A1MEN1KMT2AKIF11KIF23
SCHEMBL4516228 0.73 KIF11 (0.55) ALDH1A1MEN1KMT2AKIF11CYP2C19
SCHEMBL4524272 0.73 KIF11 (0.55) ALDH1A1MEN1KMT2AKIF11CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482343-B2 Compounds, methods and compositions CYTOKINETICS, INC. (US) 2009-01-27 — — US disclosed
US-20070135432-A1 Compounds, methods and compositions CYTOKINETICS, INC. 2007-06-14 — — US disclosed
US-7166595-B2 Compounds, methods and compositions CYTOKINETICS, INC. (US) 2007-01-23 — — US disclosed
US-20040077662-A1 Compounds, methods and compositions CYTOKINETICS, INC. 2004-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077662-A1 Compounds, methods and compositions ALPP, PCNA, MKI67 ALDH1A1 2640/4885MEN1 1613/4885KMT2A 1902/4885
US-20070135432-A1 Compounds, methods and compositions ALPP, PCNA, MKI67 ALDH1A1 2640/4885MEN1 1613/4885KMT2A 1902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback